Da-Wei Yang1,2, Yong Zhang1,2, Qun-Ying Hong1,2, Jie Hu1,2, Chun Li1,2, Bai-Shen Pan3, Qun Wang4, Fei-Hong Ding1, Jia-Xian Ou1, Fang-Lei Liu1, Dan Zhang1, Jie-Bai Zhou1, Yuan-Lin Song1,2, Chun-Xue Bai1,2,5. 1. Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. 2. Shanghai Respiratory Research Institute, Shanghai, China. 3. Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. 4. Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. 5. State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
Abstract
BACKGROUND: This study applied a combined cancer biomarker panel to clinically identify small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) in a high-risk population. METHODS: The serum levels of 4 biomarkers (progastrin-releasing peptide [ProGRP], carcinoembryonic antigen [CEA], squamous cell carcinoma antigen [SCC], and cytokeratin 19 fragment [CYFRA21-1]) were determined in 153 patients with a high risk of lung cancer (12 with a new diagnosis of SCLC, 52 with NSCLC, and 89 without lung cancer). Information about diagnosis delays was collected through interviews of all participants. RESULTS: Significantly higher serum levels of ProGRP (P < .0001) were found among the SCLC patients versus the rest of the population. A receiver operating characteristic curve analysis established the cutoff values of ProGRP, CEA, SCC, and CYFRA21-1 as 300 pg/mL, 7.3 ng/mL, 3 ng/mL, and 6.5 ng/mL, respectively. The sensitivity and specificity of ProGRP in diagnosing SCLC were 75% and 100%, respectively. Among the 14 lung cancer patients with a false-negative computed tomography (CT) result, the diagnostic panel detected 8 additional cancers. CONCLUSIONS: This panel increased the diagnostic specificity for high-risk subjects (those with renal failure being excluded), and auxiliary to a CT scan, it increased the sensitivity for patients with lung cancer. These results might be applied to shorten the diagnosis delay at health care institutions in China.
BACKGROUND: This study applied a combined cancer biomarker panel to clinically identify small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) in a high-risk population. METHODS: The serum levels of 4 biomarkers (progastrin-releasing peptide [ProGRP], carcinoembryonic antigen [CEA], squamous cell carcinoma antigen [SCC], and cytokeratin 19 fragment [CYFRA21-1]) were determined in 153 patients with a high risk of lung cancer (12 with a new diagnosis of SCLC, 52 with NSCLC, and 89 without lung cancer). Information about diagnosis delays was collected through interviews of all participants. RESULTS: Significantly higher serum levels of ProGRP (P < .0001) were found among the SCLCpatients versus the rest of the population. A receiver operating characteristic curve analysis established the cutoff values of ProGRP, CEA, SCC, and CYFRA21-1 as 300 pg/mL, 7.3 ng/mL, 3 ng/mL, and 6.5 ng/mL, respectively. The sensitivity and specificity of ProGRP in diagnosing SCLC were 75% and 100%, respectively. Among the 14 lung cancerpatients with a false-negative computed tomography (CT) result, the diagnostic panel detected 8 additional cancers. CONCLUSIONS: This panel increased the diagnostic specificity for high-risk subjects (those with renal failure being excluded), and auxiliary to a CT scan, it increased the sensitivity for patients with lung cancer. These results might be applied to shorten the diagnosis delay at health care institutions in China.
Authors: Lorenz Kuessel; Harald Zeisler; Robin Ristl; Julia Binder; Petra Pateisky; Maximilian Schmid; Julian Marschalek; Thomas Perkmann; Helmuth Haslacher; Heinrich Husslein Journal: BMC Pregnancy Childbirth Date: 2016-11-03 Impact factor: 3.007
Authors: Jae-Eun Lee; Jin-Hyun Lee; Maria Hong; Seul-Ki Park; Ji-In Yu; So-Youn Shin; Shine Young Kim Journal: Osong Public Health Res Perspect Date: 2016-11-16
Authors: Sonia Blanco-Prieto; Loretta De Chiara; Mar Rodríguez-Girondo; Lorena Vázquez-Iglesias; Francisco Javier Rodríguez-Berrocal; Alberto Fernández-Villar; María Isabel Botana-Rial; María Páez de la Cadena Journal: Sci Rep Date: 2017-01-24 Impact factor: 4.379